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1. Introduction 
1.1. Chemopreventive agents 
Chemoprevention is a promising and relatively new approach to cancer prevention that has 
precedence in cardiology, in which cholesterol lowering antihypertensive, and antiplatelet 
agents are administered to prevent coronary heart disease in high-risk individuals [1]. 
Chemoprevention can be defined as “the use of natural or synthetic chemical compounds to 
reverse, suppress or to prevent one or more of the biological events leading to the 
development of invasive cancer”  
A chemopreventive strategy could potentially either prevent further DNA damage that 
might enhance carcinogenesis or suppress the appearance of the cancer phenotype [2]. 
Chemopreventive agents inhibit or reverse cellular events associated with tumor initiation, 
promotion, and/or progression. The mechanism of chemoprotective activities might 
correlate and balance between phase I + phase II enzymes levels, and influence cellular 
macromolecules, transporters, release of carcinogens, or DNA adducts and DNA repair [3].  
More than 1000 potential chemopreventive agents have been identified in dietary sources, 
and many are being tested in vitro and in vivo systems with a variety of cancer types. 
Identification and testing of a successful chemopreventive agent is a long process, requiring 
in vitro studies, animal efficacy and toxicity studies, and eventually lengthy human clinical 
trials [4].  
1.2. Mechanisms of action of chemopreventive agents 
Broadly defined on the basis of their mechanisms of action, chemopreventive agents can be 
grouped into two general classes: blocking agents and suppressing agents. Blocking agents 
(e.g., flavonoids, oltipraz, indoles, and isothiocyanates) prevent carcinogenic compounds 
 Carcinogenesis 240 
from reaching or reacting with critical target sites by preventing the metabolic activation of 
carcinogens or tumor promoters via enhancing detoxification systems and by trapping 
reactive carcinogens [5]. Suppressing agents (e.g., vitamin D and related compounds, 
nonsteroidal anti-inflammatory drugs [NSAIDS], vitamin A and retinoids, DFMO (2-
difluoromethylornithine), monoterpenes and calcium) prevent the evolution of the 
neoplastic process in cells that would otherwise become malignant. Mechanisms of action 
for suppressing agents are not well understood. Some produce differentiation, some 
counteract the consequences of genotoxic events such as oncogene activation, some inhibit 
cell proliferation, and some have undefined mechanisms [5].  
An ideal chemopreventive agent should have 1. Little or no toxic effects 2. High efficacy 
against multiple sites 3. Capability of oral administration 4. a known mechanism of action 5. 
Human acceptance [6]. A chemopreventive program identifies and accesses specific chemical 
substances, many naturally occurring in foods, with the potential to prevent cancer initiation 
and to either slow or reverse the progression of premalignant lesions to invasive cancer. 
1.3. Types of chemopreventive agents: 
Promising chemopreventive agents being investigated include micronutrients (e.g. vitamin 
A, C and E, β-carotene, molybdenum, and calcium), phytochemicals (e.g. indoles, 
polyphenols, isothiocyanates, flavonoids, monoterpenes, and organosulfides), and 
synthetics (e.g. vitamin A derivatives, piroxicam, tamoxifen, 2-difluoromethylornithine 
[DFMO] and oltipraz). More than 40 promising agents and agent combinations are being 
evaluated clinically as chemopreventive drugs for major cancer targets [7].  
1.3.1. Synthetic chemopreventive agents (Non-Steroidal-anti-inflammatory drugs): 
Several studies have reported a 40-50% decrease in the relative risk of colorectal cancer in 
persons who are continuous users of aspirin or other non steroidal anti-inflammatory drugs 
(NSAIDS) [8], suggesting that these drugs can serve as effective cancer chemopreventive 
agents. Hixson et al., [9] showed that the synthesis of prostaglandins is limited by 
cyclooxygenase. NSAIDS reversibly interrupted prostaglandin synthesis by inhibiting 
cyclooxygenase. NSAIDS can prevent tumor formation by their actions on prostaglandins, 
which can have an immune modulating effect. High levels of prostaglandin E2 can suppress 
the immune system, which keeps malignant cells in check. 
Other mechanisms that can explain the antiproliferative antitumor effects of NSAIDS 
include: interference with membrane-associated processes, such as G-protein signal 
transduction and transmembrane calcium influx, and inhibition of other enzymes, such as 
phospho-diesterase, folate-dependant enzymes, and cyclic adenosine-5`-monophosphatase-
dependent protein kinase, as well as enhancement of immunologic responses and cellular 
apoptosis [10].  
At a macroscopic level, NSAIDS prevent incident neoplasia (adenomas and carcinomas), 
and suppress the growth of carcinomas. Therefore, NSAIDS are effective when given 
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“early” (proceeding adenoma-formation), as well as “late” (following the emergence of 
adenomas) [11].  An alternative explanation for the efficacy of NSAIDS in the prevention of 
colorectal cancer is their ability to scavenge reactive oxygen species [12]. 
1.3.2. Naturally-occurring chemopreventive agents: 
Frequent consumption of fruits and vegetables has been associated with lower incidence of 
cancers at different organ sites. Several factors can contribute to this association, first, the 
nutrients in fruits and vegetables, notably vitamin C, vitamin E, folic acid, provitamin A, 
selenium and zinc, are essential for normal cellular functions, a deficiency in these nutrients 
can enhance the susceptibility of an individual to cancer, second, some nutrients, such as 
vitamin C, vitamin E, selenium and β-carotene, at levels above nutritional needs, can display 
inhibitory activities against carcinogenesis. A third factor is that non-nutritive constituents, 
such as polyphenols, organosulfur compounds, and indoles have anticarcinogen activities. 
Finally, fruits and vegetables contribute fibers and bulkiness to the diet. Persons who 
consume large amounts of fruits and vegetables can eat smaller amounts of meat and other 
animal products that can contribute to higher cancer incidence in the western countries. 
Supplementation with these antioxidant nutrients apparently produces a protective effect 
against cancer. 
Comprehensive reviews of case-control and prospective cohort studies found that the 
relationship between high vegetable and fruit intake and reduced cancer risk appears to be 
strongest for cancers of the alimentary and respiratory tracts (cancers of the colon, 
esophagus, oral cavity and lung) and weakest for hormone related cancers (cancers of the 
breast, ovary, cervix, endometrium and prostate) [13-15]. Reduced cancer risk has been 
linked primarily to consumption of raw vegetables and fresh fruits (citrus, carrots, green leaf 
vegetables, cruciferous vegetables, soy products, and whole grain wheat products) [13-15].  
The beneficial effect of vegetables, fruits and whole grains can be due to either individual or 
combined effects of their constituents, including, fiber, micronutrients and phytochemicals.  
2. Dietary polyphenols and cancer chemoprevention 
Polyphenols constitute one of the largest and ubiquitous groups of phytochemicals. One of 
the primary functions of these plant-derived polyphenols is to protect plants from 
photosynthetic stress, reactive oxygen species, and consumption by herbivores. Polyphenols 
are also an essential part of the human diet, with flavonoids and phenolic acids being the 
most common ones in food. Not surprisingly, there is a growing realization that lower 
incidence of cancer in certain populations can probably be due to consumption of certain 
nutrients, and especially polyphenol rich diets. Consequently, a systematic dissection of the 
chemopreventive potential of polyphenolic compounds in the recent years has clearly 
supported their health benefits, including anti-cancer properties. Given the challenges of 
cancer therapy, ‘chemoprevention’-which uses pharmacological or natural agents to 
impede, arrest or reverse carcinogenesis at its earliest stages’ remains the most practical and 
promising approach for the management of cancer patients [16]. 
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Till date, A substantial number of studies in cultured cells, animal models and human 
clinical trials have illustrated a protective role of dietary polyphenols against different types 
of cancers [17–20]. Polyphenols are present in fruits, vegetables, and other dietary 
botanicals. Some estimates suggest that more than 8000 different dietary polyphenols exist, 
and these can be divided into ten different general classes based on their chemical structure 
[21]. Phenolic acids, flavonoids, stilbenes and lignans are the most abundantly occurring 
polyphenols that are also an integral part of everyday nutrition in populations worldwide. 
Some of the common examples of the most studied and promising cancer chemopreventive 
polyphenols include EGCG (from green tea), curcumin (from curry) and resveratrol (from 
grapes and berries). Significant gains have been made in understanding the molecular 
mechanisms underpinning the chemopreventive effects of polyphenols, and consequently, a 
wide range of mechanisms and gene targets have been identified for individual compounds. 
Various mechanistic explanations for their chemopreventive efficacy include their ability to 
interrupt or reverse the carcinogenesis process by acting on intracellular signaling network 
molecules involved in the initiation and/or promotion of cancer, or their potential to arrest 
or reverse the promotion stage of cancer [22; 23]. Polyphenolic compounds can also trigger 
apoptosis in cancer cells through the modulation of a number of key elements in cellular 
signal transduction pathways linked to apoptosis (caspases, bcl-2 genes) [17; 22; 23]. Several 
elegant reviews have described in detail specific genetic and signaling mechanisms that are 
targeted by different polyphenols, and this is beyond the scope of this review article [24–26]. 
However, recent research has suggested that some of the chemopreventive potential of 
dietary polyphenols can in part be due to their ability to modulate epigenetic alterations in 
cancer cells. This is of interest; as epigenetic modifications occur early and are potentially 
reversible, making dietary polyphenol-induced chemoprevention of various human cancers 
an attractive possibility from a clinical standpoint. However, the mechanism of how 
flavonoids do regulate and effect various epigenetic modifications in cancer cells is a topic 
that is still in its infancy. Nevertheless, increasing number of reports has repeatedly shown 
the promise of epigenetic prevention and possibly therapy by dietary polyphenols.  
2.1. Tea   
Tea (Camellia sinensis), next to water, is the most popular beverage consumed by over two 
thirds of the world’s population. The Chinese used tea as a medical drink as early as 3000 
BC, and by the end of the sixth century as a beverage. Tea essentially signifies two or three 
leaves and the terminal apical buds of the shrubs C. sinensis, Camellis asamica and other 
southern varieties. The cultivation area of the tea has gradually expanded in the world, 
especially in tropical countries, and the total cultivation area has expanded to 2,300,000 ha 
with a total amount of production of 2,600,000 t [27]. 
An estimated 2.5 million metric tons of dried tea are manufactured annually. Of this amount 
about 20% is green tea, mainly consumed in Asian countries where tea is a major beverage. 
About 78% is black tea mainly consumed in the western nations and some Asian countries 
and about 2% is oolong tea mainly produced and consumed in South Eastern China. 
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2.1.1. Chemistry and mechanism of action of tea polyphenols: 
Manufacture of black tea takes place by crushing the leaves causing polyphenol oxidase-
dependent oxidative polymerization that leads to the formation of theaflavins, thearubigins 
and other oligomers in a process known as fermentation. Theaflavins (about 1% - 2% of the 
total dry matter of black tea) including theaflavin, theaflavin-3-O-gallate, theaflavin-3/-O-
gallate and theaflavin-3-3/-O-digallate, possess benzotropolone rings with dihydroxy or 
trihydroxy substitution systems which give the characteristic color and taste of black tea. 
About 10 - 20% of the dry weight of black tea is due to thearubigens, which are even more 
extensively oxidized and polymerized, have a wide range of molecular weights and are less 
well characterized.  
Oolong tea, a partially fermented tea, contains monomeric catechins, theaflavins and 
thearubigins. Some characteristic components, such as epigallocatechin esters, theasinensins, 
dimeric catechins and dimeric proanthocyanidins are also found in oolong tea. 
Commercial green tea is made by steaming or drying fresh tea leaves at elevated 
temperature. Its chemical composition is similar to that of fresh tea leaves. Green tea 
contains polyphenols that include flavanols, flavandiols, flavonoids and phenolic acids. 
These compounds can account for up to 30% of the dry weight. Most of the green tea 
polyphenols are flavonols commonly known as catechin. Some major green tea catechins are 
epigallocatechin-3-gallate (EGCG), (-) - epigallocatechin (EGC), epicatechin-3-gallate (ECG), 
- (-) -epicatechin (EC), (+) -gallocatechin and (+)-catechin (Figure 1). Caffeine, theobromine 
and theophylline the principal alkaloids account for about 4% of the dry weight. 
 
Figure 1. Components of green tea 
It has been stated that a cup (200 ml) of green tea contains about 142 mg EGCG, 65 mg EGC, 
17 mg EcC and 76 mg caffeine. The most important chemicals present in tea, which are of 
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considerable pharmacological significance, are the polyphenols and caffeine [28].  
Polyphenols are present to the extent of 30-35% in the dry tea leaf and determine the quality 
of the beverage. The amount of polyphenols depends on the genetic make up of tea and 
environmental factors such as climate, light, rainfall, temperature, nutrient availability and 
leaf age [27].  
Because the mechanisms of antimutagenesis and anticarcinogenesis by tea polyphenols vary 
for different cancers and for the same cancer in different population, tea consumption can 
affect carcinogenesis only in selected situations. Many laboratory studies have demonstrated 
inhibitory effects of tea preparation and tea polyphenols against tumor formation and 
growth. This inhibitory effect is believed to be mainly due to the antioxidative and possible 
antiproliferative effects of polyphenolic compounds in green and black tea. These 
polyphenolics can also inhibit carcinogenesis by blocking the endogenous formation of N-
nitroso compounds, suppressing the activation of carcinogen and trapping of genotoxic 
agents. Yang and Wang [28] showed that tea polyphenols also have high complexation 
affinity to metals, alkaloids and biologic macromolecules such as lipids, carbohydrates, 
proteins and nucleic acids.  
Work of Kuroda and Hara [27] illustrates that the polyphenols in tea have a strong radical 
scavenging and reducing activity. They capture and detoxify radicals of various promoters 
of carcinogenesis and radicals produced in the process of exposure to radiation and light. 
Since tea polyphenols inactivate enzyme and virus activity, they could be effective against 
carcinogenesis caused by some viruses. Tea polyphenols exert their inhibitory actions via 
various mechanisms at different stages of mutagenesis, carcinogenesis, invasion and 
metastasis of tumor cells; they act extracellularly as desmutagens and intracellularly as bio-
antimutagens. Tea polyphenols modulate metabolism, block, suppress, or affect DNA 
replication and repair effects. 
2.1.2. The health effects of green tea 
Green tea has been extensively studied in people, animals, and laboratory experiments. 
Results from these studies suggest that green tea can be useful for the several health 
conditions. 
It has been found that green tea consumption is significantly associated with a lower risk of 
mortality due to stroke [29] and pneumonia [30] and imparts a lower risk of cognitive 
impairment [31], depression [32], and psychological distress [33]. These results have been 
confirmed by other researchers [34–37]. In addition, other epidemiologic studies have 
indicated that green tea consumption is associated with a lower risk of osteoporosis [38, 39], 
and randomized placebo-controlled trials have indicated that green tea is effective in 
lowering cardiovascular risk factors [40, 41]. Because all of the above conditions are major 
causes of functional disability [42–44], it is expected that green tea consumption would 
contribute to disability prevention. Green tea consumption is associated with a lower risk of 
developing functional disability. 
 
Cancer Chemoprevention by Dietary Polyphenols 245 
Atherosclerosis 
Population-based clinical studies indicate that the antioxidant properties of green tea can 
help prevent atherosclerosis, particularly coronary artery disease. (Population-based studies 
mean studies that follow large groups of people over time or studies that are comparing 
groups of people living in different cultures or with different dietary habits.) Researchers 
are not sure why green tea reduces the risk of heart disease by lowering cholesterol and 
triglyceride levels. Studies show that black tea has similar beneficial effects. In fact, 
researchers estimate that the rate of heart attack decreases by 11% with consumption of 3 
cups of tea per day [45].  
High cholesterol and cardiovascular Disease 
Research shows that green tea lowers total cholesterol and raises HDL ("good") cholesterol 
in both animals and people. One population-based clinical study found that men who drink 
green tea are more likely to have lower total cholesterol than those who do not drink green 
tea. Results from one animal study suggest that polyphenols in green tea can block the 
intestinal absorption of cholesterol and promote its excretion from the body. In another 
small study of male smokers, researchers found that green tea significantly reduced blood 
levels of harmful LDL cholesterol. 
Substantial evidence from in vitro and animal studies indicates that green tea (GT) 
preparations inhibit cardiovascular disease (CVD) processes [46-49]. In a previous 
observational study, it has been shown that GT consumption was associated with a 
significantly lower risk of mortality due to CVD among middle-aged adults [50]. The study 
also indicated that GT consumption was associated with reduced mortality from cerebral 
infarction but not with mortality from cerebral hemorrhage. These associations were 
consistent with those reported in another observational study [51]. 
Obesity 
Obesity and its related metabolic abnormalities, including insulin resistance, alterations in 
the insulin-like growth factor-1 (IGF-1)/IGF-1 receptor (IGF-1R) axis, and the state of chronic 
inflammation, increase the risk of colorectal cancer (CRC) and hepatocellular carcinoma 
(HCC). However, these findings also indicate that the metabolic disorders caused by obesity 
might be effective targets to prevent the development of CRC and HCC in obese 
individuals. Green tea catechins (GTCs) possess anticancer and chemopreventive properties 
against cancer in various organs, including the colorectal and liver. GTCs have also been 
known to exert anti-obesity, antidiabetic, and anti-inflammatory effects, indicating that 
GTCs might be useful for the prevention of obesity-associated colorectal and liver 
carcinogenesis. Further, branched-chain amino acids (BCAA), which improve protein 
malnutrition and prevent progressive hepatic failure in patients with chronic liver diseases, 
might be also effective for the suppression of obesity-related carcinogenesis because oral 
supplementation with BCAA reduces the risk of HCC in obese cirrhotic patients. BCAA 
shows these beneficial effects because they can improve insulin resistance. Here, we review 
the detailed relationship between metabolic abnormalities and the development of CRC and 
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HCC. We also review evidence, especially that based on our basic and clinical research 
using GTCs and BCAA, which indicates that targeting metabolic abnormalities by either 
pharmaceutical or nutritional intervention can be an effective strategy to prevent the 
development of CRC and HCC in obese individuals [52]. 
Diabetes 
Several studies have reported a protective effect for tea consumption on incident diabetes, 
and the results of a recent meta-analysis indicated that drinking more than 3–4 cups of tea 
(black, green or oolong) per day decreases the risk of Diabetes Mellitus by 20% [53]. Despite 
very high intake of black tea, no significant association for black tea consumption was 
observed, but an inverse correlation was found between green tea drinking and diabetes 
prevalence. Several animal and human studies have shown an antidiabetic effect for green 
tea polyphenols, specifically epigallocatechin gallate (EGCG) [54-57]. EGCG induces its 
antidiabetic effects mostly through reduced hepatic glucose production and enhanced 
pancreatic function [56]. Green tea has been shown to improve glucose tolerance and has 
been suggested as a prophylactic agent against diabetes [55]. 
Weight loss 
Clinical studies suggest that green tea extract can boost metabolism and help burn fat. One 
study confirmed that the combination of green tea and caffeine improved weight loss and 
maintenance in overweight and moderately obese individuals. Some researchers speculate 
that substances in green tea known as polyphenols, specifically the catechins, are 
responsible for the herb's fat-burning effect. 
Cancer  
Many studies suggest an inverse relationship between green tea intake and the risk of a 
variety of cancers, although other studies have found no association. Clinical trials have 
been small and heterogenous with contradictory results. Dietary, environmental, and 
population differences can account for these inconsistencies [58]. 
Several population-based clinical studies have shown that both green and black teas help 
protect against cancer. For example, cancer rates tend to be low in countries such as Japan 
where people regularly consume green tea. However, it is not possible to determine from 
these population-based studies whether green tea actually prevents cancer in people. 
Emerging clinical studies suggest that the polyphenols in tea, especially green tea, can play 
an important role in the prevention of cancer [59].  
Bladder Cancer. Only a few clinical studies have examined the relationship between bladder 
cancer and tea consumption. In one study that compared people with and without bladder 
cancer, researchers found that women who drank black tea and powdered green tea were 
less likely to develop bladder cancer. A follow-up clinical study by the same group of 
researchers revealed that bladder cancer patients (particularly men) who drank green tea 
had a substantially better 5-year survival rate than those who did not. Other study has 
demonstrated the anti-oxidant properties of green tea extract (GTE) against human bladder 
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uroepithelial cells. The data demonstrate that under in vitro conditions, green tea extract can 
afford both normal and tumorigenic human bladder urothelial cells protection (i.e., prevent 
apoptosis) to various degrees after chemical insult with H2O2 [60]. 
Breast Cancer. Although tea has been extensively investigated in in vitro and in vivo studies, 
few epidemiologic studies have evaluated the relationship between green tea and breast 
cancer risk. The results from these studies are inconsistent [61-63]. In general, the cohort 
studies, all based in Japan, report no significant association [61] and the case-control studies 
[62, 63], based on Asian-American or Chinese populations, all report an inverse relationship 
between green tea and breast cancer risk [62]. Previous studies have not evaluated the 
relationship between green tea consumption and pre- and postmenopausal breast cancer. 
The most recent meta-analysis included 7 (2 cohort, 1 nested case–control and 4 case–
control) epidemiological studies of green tea and breast cancer that were published as of 
December 2008 [64]. An inverse association between green tea and breast cancer risk was 
reported from case–control data, while no association was observed from cohort data [64]. 
The nested case–control study reported no association [65], so even if it had been included 
as a cohort study in the pooled analyses, the overall finding would have remained the same. 
In summary, green tea could exert beneficial effects on breast carcinogenesis through 
inhibition of estrogen’s pro-carcinogenic activity either alone by itself or in combination 
with other estrogen-inhibiting factors. Black tea does not appear to have protective effects 
on breast cancer incidence, and can increase risk of hormone-dependent tumors. Future 
research is needed to elucidate the interactive role of tea catechins and other dietary cancer-
inhibitory compounds in mammary carcinogenesis in humans. 
Ovarian Cancer. In a clinical study conducted on ovarian cancer patients in China, 
researchers found that women who drank at least one cup of green tea per day survived 
longer with the disease than those who did not drink green tea. In fact, those who drank 
green tea lived the longest. Other studies found no beneficial effects [66, 67]. In view of the 
variations in rates of breast cancer and tea-drinking practices, one case–control study was 
conducted in Southeast China to evaluate the association between breast cancer and tea 
consumption measured by type, duration, frequency and quantity of tea and the interactions 
between tea consumption and other lifestyle factors. 
Esophageal Cancer. In the Indian studies [68-70], some results indicated that tea (presumably 
black tea) consumption could be responsible for the development of esophageal cancer. The 
authors indicated that this result could be due to drinking hot tea, which was shown to 
occur a couple of decades before in a Chinese cohort. The other possibility could be that 
Indians drink their black tea with milk, which was shown before to counteract positive 
effects of tea.  
The higher content of tea catechins present in green tea than in black tea can explain the 
more consistent inverse association between tea and esophageal cancer risk in studies 
conducted in China and Japan than in European and American countries. The putative 
protective effect of tea consumption, if any, on esophageal cancer development could be 
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confounded and/or overshadowed by the thermal effect of tea beverages, if consumed at 
high temperature, as well as cigarette smoking or alcohol intake. Future prospective cohort 
studies are required to collect detailed information on tea temperature and histories of 
tobacco and alcohol use that can then be adjusted for when evaluating the protective effect 
of tea on esophageal cancer. 
Prostate Cancer. Among all cancers, prostate cancer is an ideal candidate disease for 
chemoprevention because it is typically diagnosed in men ages >50 years and has a high 
latency period [71, 72]. Therefore, even a slight delay in the progression of this disease by 
chemopreventive intervention could result in a substantial reduction in the incidence of the 
disease and, more importantly, improve the quality of life of the patients [71, 72]. Evidences 
collected from geographic, epidemiologic, and migration studies suggest that frequent 
consumption of green tea is associated with lower frequencies of prostate cancer in Asian 
populations in general compared with those in western societies [73-77]. Laboratory and 
preclinical animal studies also indicate a protective role of green tea against prostate cancer 
[78-82]. 
In summary, observational studies do not provide strong evidence for a protective effect of 
green tea or black tea intake against the development of prostate cancer. There is some 
suggestive evidence that green tea intake can reduce the risk of advanced prostate cancer. 
The phase II clinical trials have provided encouraging evidence in the development of green 
tea catechins as a chemopreventive agent against prostate carcinogenesis.  
Skin Cancer. There has been considerable interest in the use of naturally occurring plant 
products, including polyphenols, for the prevention of UV-induced skin photodamage 
primarily including the risk of skin cancer. Polyphenols, specifically dietary, possessing 
anti-inflammatory, immunomodulatory and anti-oxidant properties are among the most 
promising group of compounds that can be exploited as ideal chemopreventive agents for a 
variety of skin disorders in general and skin cancer in particular. In this respect, 
chemoprevention offers a realistic strategy for controlling the risk of cancers. Furthermore, a 
chemopreventive approach appears to have practical implications in reducing skin cancer 
risk because, unlike the carcinogenic environmental factors that are difficult to control, 
individuals can modify their dietary habits and lifestyle in combination with a careful use of 
skin care products to prevent the photodamaging effects in the skin. Studies from our 
laboratory have shown the efficacy of naturally occurring polyphenols, such as green tea 
polyphenols (GTPs), silymarin from milk thistle and proanthocyanidins from grape seeds 
(GSPs), against UV radiation-induced inflammation, oxidative stress, DNA damage and 
suppression of immune responses [83]. 
Stomach cancer. Recently, Myung et al. conducted a meta-analysis investigating the 
quantitative association between the consumption of green tea and the risk of stomach 
cancer in humans [84]. The analysis included 13 (5 cohort and 8 case–control) studies, all 
conducted in Japanese or Chinese populations. An inverse association was seen in case–
control studies only, but not in cohort studies. However, in a recent pooled analysis of 6 
cohort studies that included more than 218,000 Japanese men and women aged 40 years or 
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older and more than 3500 incident stomach cancer cases found a statistically significant, 
inverse association between green tea consumption and stomach cancer risk in women, but 
not in men [85]. Compared with those drinking <1 cup/day, women with the consumption 
of ≥5 cups/day green tea had an approximately 20% decreased risk of stomach cancer. This 
protective effect was primarily seen among female nonsmokers [85]. 
In the study by Kinlen et al., the positive association between black tea consumption and 
stomach cancer death could be, at least partly, due to the effects of smoking and social class 
[86]. Whereas in the cohort analysis by Khan et al. that included approximately 3100 
Japanese men and women, black tea consumption was associated with a statistically 
significantly increased risk of stomach cancer for women [87]. Given the small sample size 
and low intake of black tea in a population that usually consumed green tea, this positive 
association could be a chance finding. 
Both case–control and cohort studies demonstrated an inverse association between green tea 
consumption and risk of stomach cancer. The protection can be stronger for women than 
men since the former are less likely to smoke cigarettes or drink alcoholic beverages. There 
is lack of evidence in support of a protective role of black tea consumption against the 
development of stomach cancer. 
Cervical Cancer. Cancer of the cervix is the third most common malignancy worldwide in 
women, and the most common gynecologic cancer in the developing world. In developed 
countries, prevention of cervical cancer achieved by the widespread and systematic use of 
cervical cytologic screening, has contributed to the successful decrease in the incidence of 
invasive cervical carcinomas. In the developing world, cervical cancer remains a common 
malignancy impacting the lives of women during their period of highest productivity. 
Especially in low-resource settings, an inexpensive dietary chemo-preventive intervention 
would be an attractive adjunct to existing cervical cancer prevention programs It is well-
known that the regular consumption of fruits and vegetables is highly associated with the 
reduced epidemiologic risk of different types of cancer [88-91] and green tea consumption is 
associated with lowering certain cancer incidences including cervical cancer [92]. 
Lung Cancer. Numerous epidemiological studies examined the association between green tea 
or black tea consumption and risk of lung cancer. A systematic review was conducted to 
evaluate the association between the consumption of green tea or black tea and lung cancer 
risk among 19 studies (13 case–control, 6 prospective cohort) that were published prior to 
September 2007 [93]. Among the 8 studies examining green tea and lung cancer risk, 3 
reported a significantly lower risk while one reported a significantly increased risk of lung 
cancer with high green tea consumption. The remaining 4 studies reported no association 
[93]. More recently, Tang et al. conducted a similar meta-analysis for green tea or black tea 
consumption with lung cancer risk [94]. This analysis included 22 studies published from 
1966 to November 2008 and 12 of them also were included in the analysis by Arts [93]. 
Twelve studies examined the association between green tea and lung cancer risk. A 
statistically significant 18% decreased risk of lung cancer was associated with every 2 
cups/day of green tea consumption. This inverse green tea-lung cancer association was 
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slightly stronger for prospective cohort studies than retrospective case–control studies. The 
protective effect of green tea consumption on lung cancer risk was confined to nonsmokers 
[94]. 
In the same review by Arts [93], 11 of the 19 studies included examined the association 
between black tea consumption and lung cancer risk. Among them, two reported a 
statistically significantly reduced risk while one reported an increased risk for lung cancer 
associated with black tea intake. The remaining 8 studies reported a null association [93]. In 
a more recent meta-analysis by Tang et al., no statistically significant association was 
observed between black tea consumption and lung cancer risk based on 14 studies included 
[94]. Not included in the meta-analyses was a case–control study in Los Angeles, CA with 
558 cases and 837 controls. The results showed that high consumption of dietary 
epicatechin, mainly from black tea, was associated with significantly reduced risk of lung 
cancer, especially among smokers [95]. 
One potential mechanism for the chemopreventive effect of tea on carcinogenesis is the 
strong antioxidant effect of tea polyphenols. Hakim et al. conducted a phase II randomized 
controlled tea intervention trial to evaluate the efficacy of regular green tea drinking in 
reducing DNA damage as measured by urinary 8-hydroxydeoxyguanosine among heavy 
smokers [96]. After consuming 4 cups/day of decaffeinated green tea for 4 months, smokers 
showed a statistically significant 31% decrease in urinary 8-hydroxydeoxyguanosine 
compared with the baseline value. In the same study, no change in urinary 8-
hydroxydeoxyguanosine was seen among smokers assigned to the black tea group [96]. 
These findings support that tea catechins, with highest levels in green tea, exert their 
antioxidative role in reducing the formation of 8-hydroxydeoxyguanosine. However, a lack 
of inverse association between green tea consumption and lung cancer risk in smokers 
suggest that the antioxidation mechanism plays a limited role in reducing the risk of lung 
cancer development. Furthermore, the protective effect of tea consumption on lung cancer 
development for nonsmokers, especially among women, indicates an alternative cancer-
preventive mechanism of tea that is not driven by antioxidation. Additional experimental 
studies that utilize animal models to elucidate the cancer-preventive mechanisms of tea 
catechins on lung carcinogenesis are needed. 
Pancreatic Cancer. Similar to other gastrointestinal organs, epidemiological studies have 
provided mixed results on the association between tea consumption and risk of pancreatic 
cancer. There are a limited number of studies that examined the association between green 
tea consumption and pancreatic cancer. From an early hospital-based case–control study in 
Japan (124 cases and 124 matched controls), no association was observed for pancreatic 
cancer risk with green tea drinking [97]. In contrast, analyses from a population based case–
control study conducted in Shanghai, China (451 cases and 1552 controls) demonstrated a 
statistically significant inverse association with increased green tea consumption and 
pancreatic cancer risk [98]. A prospective cohort study in Japan involved more than 100,000 
Japanese adults with up to 11 years of follow-up and 233 incidents of pancreatic cancer cases 
did not find an association between green tea intake and pancreatic cancer risk [99]. In 
another prospective cohort study with up to 13 years of follow-up and 292 incident 
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pancreatic cancer cases in Japan, Lin et al. reported a higher percentage of dying from 
pancreatic cancer for subjects who consumed ≥7 cups/day of green tea compared with those 
<1 cup/day [100]. 
Available epidemiological data are insufficient to conclude that either green tea or black tea 
can protect against the development of pancreatic cancer. Given the short survival and rapid 
progression of pancreatic cancer, the low participation rates of pancreatic cancer patients in 
retrospective case–control studies or the use of proxy respondents in interview for collection 
of information on tea consumption and other risk factors could bias the results of case–
control studies. Prospective cohort studies offer methodological advantages over case–
control studies. Additional data from well-designed and well-executed prospective cohort 
studies are required before any conclusion on the protective effect of green tea and/or black 
tea against the development of pancreatic cancer can be reached.  
Oral cavity and pharynx Although numerous epidemiological studies examined the 
association between dietary factors and risk of oral and pharyngeal cancers [101], there are 
limited data on the effect of tea consumption on these malignancies. Combining a series of 
case–control studies in Italy with a total of 119 patients with cancer of the oral cavity and 
6147 hospital controls, La Vecchia et al. reported a reduced, but statistically non-significant, 
risk of oral cancer with black tea consumption [102]. Using a similar approach, Tavani et al. 
combined datasets of two hospital-based case–control studies conducted in Italy and 
Switzerland, respectively, and reported no association between black tea consumption and 
oral cancer risk [103]. Recently, Ren et al. examined the association between black tea 
consumption and the risk of developing oral and pharyngeal cancers in the National 
Institutes of Health (NIH)-American Association of Retired Persons (AARP) Diet and Health 
Study [104]. 
The NIH-AARP cohort study enrolled 481,563 AARP members aged 51–71 years who 
resided in eight states of the United States in 1995–1996. After up to 8 years of follow-up, 392 
study participants developed oral cancer and 178 developed pharyngeal cancer. The study 
demonstrated a statistically significant positive relationship between consumption of hot tea 
and risk of pharyngeal cancer. There was a suggestive positive relationship between hot tea 
intake and risk of oral cancer [104]. Consumption of iced tea was not associated with risk of 
oral or pharyngeal cancer. 
There was one prospective cohort study that examined the association between green tea 
consumption and risk of oral cancer in the Japan Collaborative Cohort Study. The cohort 
consisted of 50,221 Japanese men and women aged 40–79 years at baseline and identified 37 
incident oral cancer cases after 10.3 years of follow-up. The inverse association was slightly 
stronger for women than for men [105]. The inverse relation did not reach statistical 
significance due to the relatively small number of cancer cases included in the analysis. 
A randomized, placebo-controlled, phase II clinical trial was conducted to examine the effect 
of green tea extract on the oral mucosa leukoplakia, a well established precancerous lesion 
of oral cancer [106]. Fifty-nine patients were randomly assigned to either the treatment 
group, who were given 3 g/day of a mixed green tea product composed of dried water 
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extract, polyphenols and pigments, or the placebo group. After 6 months, 37.9% patients in 
the green tea treatment arm showed reduced size of oral lesions whereas 3.4% patients had 
increased lesion size. In contrast, 6.7% patients in the placebo group had decreased and 10% 
patients had increased size of oral mucosa leukoplakia. The differences in the changes of 
lesion sizes between the treatment and placebo arms are statistically significant [106]. 
Recently, Tsao et al. completed another randomized, placebo-controlled phase II trial to 
evaluate the oral cancer prevention potential of green tea extract [107]. Forty-two patients 
with one or more histologically confirmed, bidimentionally measurable oral premalignant 
lesions with high-risk features of malignant transformation that could be sampled by biopsy 
were randomly assigned to receive 500, 750, or 1000 mg/m2 of green tea extract per day or 
placebo orally. The efficacy was determined by the disappearance of all lesions (a complete 
response) or 50% or greater decrease in the sum of products of diameters of all measured 
lesions (a partial response). At 12 weeks after the initiation of the treatment, 39 patients who 
completed the trial were evaluated; 14 (50%) of the 28 patients in the three combined green 
tea extract groups had a favorable response whereas only 2 (18.2%) of the 11 patients in the 
placebo group showed the similar response. A dose-dependent effect was observed; the 
favorable response rates were 58% in patients given 750 or 1000 mg/m2 green tea extract and 
36.4% in those given 500 mg/m2, but only 18.2% in those assigned to the placebo arm [107]. 
Although limited, data from the prospective cohort study suggest a moderate protective 
effect of green tea consumption against the development of oral cancer. Both phase II 
clinical trials further support a protective role of green tea extract against the progression of 
precancerous lesions in the oral cavity towards malignant transformation. Phase III clinical 
trials with large number of patients are required to confirm the efficacy of green tea extract 
against the formation of oral cancer in humans. Data on the effect of black tea consumption 
against the development of oral cancer are too limited to draw any conclusion. One 
prospective study showed a statistically significant inverse association between black tea 
consumption and risk of pharyngeal cancer, more epidemiological studies are warranted to 
evaluate the potential protective effect of either green tea or black tea on the development of 
pharyngeal cancer in humans. 
Large bowel. Numerous epidemiological studies have examined the association between tea 
consumption and colorectal cancer. Sun et al. conducted a meta-analysis that included 25 
epidemiological studies evaluating tea consumption and risk of colorectal cancer in 11 
countries [108]. The inverse association between green tea intake and colon cancer risk was 
mainly observed in 4 case–control studies, but not in 4 cohort studies. There was no 
relationship between green tea intake and rectal cancer risk in 6 case–control or cohort studies. 
Following the meta-analysis, several studies examined and published the results on the 
green tea consumption and colorectal cancer risk. After analyzing the database of the 
Singapore Chinese Health Study, a prospective cohort study of diet and cancer involved 
over 60,000 Chinese men and women aged 45–74 years, Sun et al. found that subjects who 
drank green tea daily had a statistically non-significant increased risk for colorectal cancer 
relative to nondrinkers of green tea. This association was confined to men and was stronger 
for colon cancer than rectal cancer, especially for the advanced stage of colon cancer [109]. 
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These data suggest that substances in green tea can exert an adverse, late-stage effect on the 
development of colorectal cancer. 
Yang et al. prospectively evaluated the association between green tea consumption and 
colorectal cancer risk in a cohort of 69,710 Chinese women aged 40–70 years, most of which 
were Lifelong nonsmokers (97.3%) or nondrinkers of alcoholic beverages (97.7%). 
Information on tea consumption was assessed through inperson interviews at baseline and 
reassessed 2–3 years later in a follow-up survey. During the first 6 years of follow-up, 256 
incident cases of colorectal cancer were identified. Regular tea drinkers had significantly 
reduced risk of colorectal cancer compared with nondrinkers. The reduction in risk was 
most evident among those who consistently reported to drink tea regularly at both the 
baseline and follow-up surveys [110]. 
There were two recent prospective studies on green tea consumption and colorectal cancer 
incidence and mortality in Japan [111, 112]. The first consisted of 96,162 Japanese men and 
women, and 1163 incident cases of colorectal cancer [111]. There was no statistically 
significant association between green tea consumption and incidence of colon and rectal 
cancers combined or separately in either men or women or both. The second cohort 
consisted of 14,001 Japanese men and women. After up to 6 years of follow-up, 43 subjects 
died from colorectal cancer. Given the small number of cases, the results should be 
interpreted with caution. Using validated biomarkers of specific tea polyphenols, Yuan et al. 
prospectively examined the urinary levels of specific tea catechins and their metabolites and 
the risk of developing colorectal cancer in the Shanghai Cohort Study as described above 
[113]. EGC, 4_-O-methyl-epigallocatechin (4_-MeEGC) and EC, and their metabolites in 
baseline urine samples were measured in 162 incident colorectal cancer cases (83 colon and 
79 rectal cancer cases) and 806 matched controls. Individuals with high prediagnostic 
urinary catechin levels had a lower risk of colon cancer. There was no association between 
urinary green tea catechins or their metabolites and risk of rectal cancer. This study 
provided a direct evidence for the chemopreventive effect of tea catechins against the 
development of colon cancer in humans [113]. 
In terms of black tea, the meta-analysis by Sun et al. [108] included 20 studies that examined 
black tea consumption and colorectal cancer risk and found no association. No association 
was found separately in case–control studies or prospective cohort studies. In our analysis 
of the Singapore Chinese Health Study, we did not find any association between black tea 
consumption and risk of colon cancer and rectal cancer combined or separately [109]. More 
recently, Zhang et al. conducted a pooled analysis for black tea intake and colon cancer risk 
on the combined dataset of 13 cohort studies conducted in North America or Western 
Europe. The analysis included 731,441 subjects and 5604 incident colon cancer cases [114]. 
Compared with nondrinkers, consumption of 900 g/day tea (approximately four 8-oz 
cups/day) was associated with a modest, but statistically significantly increased risk of colon 
cancer. This increased risk for colon cancer was only in women, but not in men. 
Epidemiological studies provided suggestive evidence to support a protective role of green 
tea consumption, especially in high amount and long-term duration of consumption, in 
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reducing the risk of colon cancer. This effect of green tea on colon carcinogenesis can 
depend on the time of exposure, where late exposure can promote the growth of colon 
tumor cells. Current epidemiological data suggest that black tea consumption can increase, 
instead of decrease, the risk of colorectal cancer. 
Kidney. Several epidemiological studies examined the relationship between tea consumption 
and kidney cancer risk. Mellemgaard et al. conducted a population-based case–control 
study that enrolled 368 renal cell cancer cases and 396 matched controls living in Denmark 
[115]. The study did not find an association between black tea consumption and renal cell 
cancer risk. Bianchi et al. conducted a population-based case–control study of renal cell 
cancer in Iowa (406 cases and 2434 controls), and found no association [116]. 
Similarly, a more recent case–control study of renal cell cancer in Italy including 767 cases 
and 1534 controls did not find any association between tea consumption and risk of renal 
cell cancer [117]. Lee et al. analyzed datasets of the Nurses’ Health Study and the Health 
Professionals Follow-up Study and found that consumption of ˃1 cup/day tea was 
associated with statistically non-significantly reduced risk of renal cell cancer relative to <1 
cup/month [118]. In a pooled analysis, Lee et al. combined data of 13 prospective cohorts 
including more than 774,000 men and women and 1478 incident renal cell cancer cases. 
Compared with nondrinkers, individuals who consumed ≥1 cups/day of tea had a 
statistically borderline significant 15% risk reduction in renal cell cancer after adjustment for 
body mass index, cigarette smoking, hypertension and other potential confounders [119]. 
All these studies were conducted in North America and West Europe and examined the 
effect of presumably black tea on renal cell cancer risk. These findings do not support a 
protective role of black tea on kidney cancer. Additional prospective epidemiological 
studies are warranted to examine the association between green tea consumption and 
kidney cancer risk. 
Glioma. Regular intake of tea was not associated with risk of adult glioma in a case–control 
study [120]. Recently Holick et al. examined the association between coffee, black tea and 
caffeine intake and risk of adult glioma in three prospective cohort studies in the United 
States. The analysis included 335 incident glioma cases. Compared with nondrinkers, there 
was a statistically non-significant, approximately 30% decreased risk of glioma incidence for 
those consuming 4 cups/week of black tea [121]. More data are warranted to draw any 
conclusion on the association between tea consumption and adult glioma risk. 
Lymphoma. Thompson et al. examined the association between black tea consumption and 
risk of non-Hodgkin’s lymphoma in the Iowa Women’s Health Study. The analysis included 
415 incident lymphoma cases during the 20 years of follow-up following baseline interview. 
No association was found between black tea consumption and risk of non-Hodgkin’s 
lymphoma [122]. 
Leukemia. A hospital-based case–control study involving 107 adults with leukemia and 110 
orthopaedic controls in China found that green tea consumption was associated with a 
statistically significant 50% decreased risk of leukemia. The inverse association was dose 
dependent with number of cups of tea per day, number of years of tea consumption, and the 
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amount of dry tea leaves consumed [123]. A similar case–control study enrolled 252 
leukemia patients aged 0–29 years and 637 sex- and age matched control subjects in Taiwan. 
Compared with nondrinkers, high intake of total tea catechins was associated with 
approximately 50% reduced risk. This inverse association was stronger in older (16–29 
years) than in the younger (0–15 years) group [124]. Given the limitations of small study size 
and hospital-based study design, further studies are warranted to confirm these results. 
2.1.3. Possible active tea components and their tissue levels 
Plasma EGCG, EGC and EC exist in free and conjugated (glucuronide and sulfate) forms. 
The plasma tea polyphenol levels in rats and mice in some anticarcinogenesis experiments 
were comparable to the peak levels in humans after consuming two or three cups of tea 
[125].  In a preliminary experiment, after administration of regular green tea in drinking 
fluid to rats, the EGCG was detected in the esophagus (410 ng/g) but not in the lung, the 
EGCG, EGC and EC levels in the small intestine and intestinal contents were rather high (1.5 
- 5.5 mg/g) due to the unabsorbed and biliary excreted glucuronides of polyphenols in the 
intestine. High EGC and EC levels were also observed in the colon tissues (1.8 and 0.3 mg/g 
respectively). Due to possible glucuronidase and esterase activities in the colon, most of the 
EGC and EC were found in the free form and EGCG was found at lower levels. EGCG has 
been usually considered the active anticarcinogenic components in tea because it is the most 
abundant polyphenol in tea.  
Hackett et al., [126] reported that three human volunteers were given 2 g of (+)- catechin and 
the metabolic changes in it were then examined by looking at their blood and urine. About 
55% of the labeled catechin was excreted in urine within 2 h after its uptake. The metabolites 
in urine were (+) - catechin, and glucuronic and sulfate compounds of 3-O-methye- (+)-
catechin. These metabolites were about ¾ of the catechin uptake. 
Matsumoto et al., [127] determined the amount of tea polyphenols in organs and tissues to 
examine the fate of catechin in the digestive canal, such as the stomach; small and large 
intestines of rats. EGCG given orally was transferred from the stomach to the small intestine 
within several hours and moved to the large intestine after 8 hours. Most of the amount of 
catechins taken in orally moved into the digestive tract and were excreted in the feces. Some 
part of the catechins was metabolized by intraintestinal bacteria and about 20% of the 
catechin can have been absorbed by the digestive organs. 
Tea catechins and crude extracts, however, have some beneficial effects on human health, 
such as suppression of high blood pressure [128], reduction of blood glucose levels [129] 
suppression of cholesterol and prevention of fat increase [130]. Tea drinking can also induce 
higher levels of glutathione [131], so that detoxification of reactive forms of carcinogens can 
occur more efficiently, other biochemical mechanisms have been hypothesized for the 
anticancer properties of tea e.g. induction of DNA repair, binding with activated 
carcinogens. Moderate tea consumption (5 cups / day an extract of about 11 g of tea) can be 
readily curable in some types of human cancer [132]. In other studies on the inhibitory 
effects of tea catechins, black tea extract and oolong tea extract and EC, EGC, ECG, EGCG 
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and other tea extracts (0.05 or 0.1%) showed a significant decrease in the number and area of 
preneoplastic glutathione S-transferase placental form (GSTP)-positive foci in the liver of 
rats [133]. 
2.1.4. Antioxidative function of tea polyphenols 
The most noteworthy properties of tea polyphenols and other flavonoids are their 
antioxidative activities. Reactive oxygen species may play important roles in carcinogenesis 
through damaging DNA, altering gene expression, or affecting cell growth and 
differentiation. The anticarcinogenic activities of tea polyphenols are believed to be closely 
related to their antioxidative properties. The findings that green tea preparations inhibited 
12-0-tetradecanoylphorbol- 1 3-acetate-induced hydrogen peroxide formation in mouse 
epidermis and NNK-induced 8-hydroxydeoxyguanosine formation in mouse lung are 
consistent with this concept. Inhibition of tumor promotion-related enzymes such as 
ornithine decarboxylase, protein kinase C, lipoxygenase, and cyclooxygenase by tea 
preparations has also been reported. Although inhibition of carcinogen activation by tea or 
green tea polyphenol fractions could be demonstrated in vitro and, in certain cases, in vivo 
[134], this mechanism was not demonstrated for NNK bioactivation in vivo. Oral 
administration of tea preparations to animals has been reported to moderately enhance the 
activities of glutathione peroxidase, catalase, glutathione S-transferase, NADPH-quinone 
oxidoreductase, uridine diphosphate-glucuronosyltransferase, and methoxyresorufin O-
dealkylase. The effects of a mild induction of these enzymes on carcinogenesis are not clear. 
Mechanisms relating to the quenching of activated carcinogens, antiviral activity, and 
enhancing immune functions have also been suggested, but their relevance to 
carcinogenesis remains to be determined. Inhibition of nitrosation by tea preparations has 
been demonstrated in vitro and in humans [135]; this may be an important factor in 
preventing certain cancers, e.g., gastric cancer, if the endogenously formed N-nitroso 
compounds are causative factors. Other results suggest that the antiproliferative effect of tea 
is important for the anticarcinogenic activity. One may speculate that tea polyphenols 
inhibit growth-related signal transduction pathways [136]. 
2.1.5. Effects of tea on mutation and genotoxicty 
As to the genotoxic profile of tea catechins when tested alone, Chang et al. [137] have shown 
that there is minimal genotoxic concern with a decaffeinated green tea catechin mixture 
(Polyphenon E) that contains about 50% epigallocatechin gallate and 30% other catechins. 
Isbrucker et al. [138] have also found no genotoxic concern with a epigallocatechin gallate 
(GTE) preparation, Teavigo. On the other hand, many studies have demonstrated that tea 
catechins could suppress the genotoxic activity of various carcinogens with both in vitro and 
in vivo systems. 
a. In vivo studies 
Imanishi et al., [139] reported that when green tea or black tea polyphenols was 
administered orally 6, 12 or 18 hours before an intraperitoneal injection of mitomycin C 
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resulted in a statistically significant decrease of micronucleus formation in mouse bone 
marrow, although, post-treatment administration had no effect. 
Hot water extracts of green tea effectively suppressed AFB1 (aflatoxin B1) induced 
chromosome aberrations in bone marrow cells in rats when given green tea extract 24 h 
before injection with AFB1 [140]. Rats administered green tea extract 2 h before or after the 
AFB1 injection showed no suppressive effect. The suppressive effect of green tea extracts on 
AFB1 induced chromosome aberration was directly related to the dose of green tea extract 
(in the range of 0.1 to 2 g/kg). Black tea or coffee given 24 or 2 h before the AFB1 injection 
produced no suppressive effect. 
De boer, [141] showed that the mutagenic potency of several chemicals including the dietary 
heterocyclic amine 2-amino-1-methyl-6-phenyl-imidazo(4,5-b) pyridine (PhIP)(the 
environmentally important aromatic hydrocarbon benzo(a)pyrene) and the food 
contaminant aflatoxin B1 can be modulated by dietary compounds including green tea in 
lacI transgenic rodent. 
Green tea effectively inhibited oxidative DNA damage and cell proliferation in liver of 2-
nitropropane (2NP) treated rats [142]. It was suggested that pyrogallol-related compounds 
of green tea such as EGCG, ECG and EGC are antimutagenic factors in the Escherichia coli 
B/R Wp2 assay system [143-146].  
Significant inhibition activity of the tea catechins ECG and EGCG, against the mutagenicity 
of Trp-P-2 and N-OH-Trp-P-2 has been found by [143] using Salmonella typhimurium, TA98 
and TA100 with and without rat liver S9 mix. EGCG has also an inhibitory effect against the 
mutagenicity of benzo[a]pyrene (B[a]P) diol epoxide in TA100 strain without S9 mix. Green 
tea has  potent suppressive effects against gene expression of the SOS response in salmonella 
typhimurium TA1535/psk 1002 induced by four nitroarenes [147]. 
A study performed by [148] reported that EGCG suppressed the direct-acting mutagenicity 
of 3-hydroxyamino-1-methyl-5H-pyrido-(4,3-b) indole (Trp-p-2(NHOH)) and 2-
hydroxyamino-6-methyldipyrido(1,2-a:3,2-d) imidazole (Glu-p-1(NHOH)) in the Ames 
salmonella test. furthermore, they added that EGCE has also a suppressive effect in the in vivo 
Drosophila mutation assays, i.e., the wing spot test, and the DNA repair test, on several 
carcinogens. 
Kada et al., [144] showed that a homogenate of Japanese green tea gave high 
bioantimutagenic activity against spontaneous mutations resulting from altered DNA-
polymerase III in strain NIG 1125 of Bacillus subtilis. They identified chemically the active 
principles and they obtained 0.85 g EC, 1.44 g EGC, 1.24 g ECG and 4.87 g EGCG from 12 g 
of a crude extract of green tea powder. 
Green tea extract reduced the levels of ischemia/reperfusion induced hydrogen peroxide, 
lipid peroxidation and oxidative DNA damage (formation of 8-hydroxydeoxyguanosine) by 
pretreatment of 0.5 or 2% green tea water extract for 3 weeks, respectively in Mongolian 
gerbils. Moreover, green tea also reduced the number of ischemia/reperfusion- induced 
apoptotic cells and locomotors activity [149]. 
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Li et al., [150] indicated that green tea, tea pigments, and mixed tea could effectively inhibit 
DMBA (7,12-dimethyl-benz(a)anthracene) induced oral carcinogenesis in hamster. 
Protection from DNA damage and suppression of cell proliferation could be important 
mechanisms of anticarcinogenic effects of the tea preparations. Another study reported that 
green tea consumption inhibited the formation of micronuclei in peripheral blood 
lymphocytes in smokers [151].  
Katiyar et al., [152] demonstrated that green tea polyphenols (GTP) prevent ultraviolet (UV)-
B-induced cyclobutane pyrimidine dimers (CPD), which are considered to be mediators of 
UVB induced immune suppression and DNA damage on human skin. It has been also 
demonstrated that standardized green tea extract protects against psoralen plus ultraviolet 
A-induced phototoxicity to human skin by inhibiting DNA damage and diminishing the 
inflammatory effects of this modality. 
Binding of AFB1 to hepatic nuclear DNA was inhibited in rats given 0.5% instant green tea 
for 2 or 4 weeks before a single injection of AFB1 [153].  
The oral administration of 0.2% green tea or 0.1% black tea for 28 days decreased the extent 
of chromosome damages (micronuclei) in the peripheral blood of mice subsequently treated 
with B[a]P [154]. 
The level of one of the two lung DNA adducts produced by the lung carcinogen NNK 
(4(methylnitrosamino)-1-(3-pyridyl)-1-butanone) during and after carcinogen treatment was 
reduced in mice given 2% green tea as their sole source of drinking water [155]. Green tea 
suppressed 8-OH-2’deoxyguanosine or 8-OH-guanosine, but not 6O-methylguanine levels, 
in lung DNA. 
Recently, it has been demonstrated that the administration of green tea extract 24 hr before 
the dimethylnitrosoamine (DMN) injection significantly suppressed DMN-induced 
chromosomal aberrations and sister chromatid exchanges. The suppression was observed 18 
hr, 24 hr and 48 hr after the DMN treatment but no suppressive effect was observed at the 
early period (6 hr and 12 hr) after the DMN treatment. Furthermore, the suppression was 
observed for all doses of DMN investigated. Mice given green tea 2 hr before the DMN 
injection displayed no suppressive effect. Mice that were given 2% green tea extract as the 
sole source of drinking water for four days before sacrifice displayed significantly 
suppressed DMN-induced chromosomal aberrations and sister chromatid exchanges [156]. 
They conclude that the suppression of DMN-induced chromosomal aberrations and sister 
chromatid exchanges should be considered as a green tea exerting a preventive action.  
b. In vitro studies  
Studies with cell lines had demonstrated that tea polyphenols affect signal transduction 
pathways, inhibit cell proliferation and induce apoptosis, but the effective concentrations 
are usually much higher than those observed in blood and tissue [157].  
Islami et al., [158] described a novel observation that EGCG displayed strong inhibitory 
effects on the proliferation and viability of HTB-94 human chondrosarcoma cells in a dose-
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dependent manner and induced apoptosis. The induction of apoptosis by EGCG via 
activation of caspase-3/cpp32 - like proteases can provide a mechanistic explanation for its 
antitumor effects. 
Supplementation with green tea extract significantly decreased malondialdehyde 
production and DNA damage after Fe(+2) oxidative treatment in jurkat T-cell line [159]. 
EGCE was effective in reducing the mutagenecity of Trp-p-2(NHOH) in mouse FM3A cells 
in culture. EGCE was also effective in inhibiting DNA single strand breaks in vitro caused by 
Glu-p-1(NHOH) [160].   
Jain et al., [161] found that the extract of green tea leaves decreased the mutagenic activity of 
N-methyl-N’-nitro-N-nitrosoguanidine (MNNG) to E.coli Wp2 in vitro in a desmutagenic 
manner. 
In cultured mammalian cells, the frequencies of mitomycin C or ultraviolet light-induced 
sister-chromatid exchanges and chromosomal aberrations were suppressed by subsequent 
treatment with tea polyphenols in the presence of liver-metabolizing enzymes (S9 fraction). 
In the absence of such enzymes, however, the tea extracts suppressed sister chromatid 
exchanges and chromosomal aberrations at low concentrations but enhanced them at high 
concentration [162]. 
It was shown that EGCG and EGC rather than ECG and EC were found to induce apoptosis 
in lovo cells. Moreover, EGCG, EGC and ECG caused the arrest at the G1-phase of the cell 
cycle, whereas EC induced the S-phase arrest [163].   
Zhao et al., [164] illustrated that after HL-60 cells were treated by tea polyphenols (250 micro 
g/ml) for 5h, DNA extracted from HL-60 cells showed a typical internucleosomal DNA 
degradation i.e. DNA ladder and apoptotic vehicles were observed. 
Ahmed et al., [165] studied the effect of green tea polyphenols and the major constituent 
epigallocatechin-3-gallate on the induction of apoptosis and regulation of cell cycle in 
human and mouse carcinoma cells and found that treatment of A431 cells with green tea 
polyphenols and its components epigallocatechin-3-gallate, epigallocatechin and 
epicatechin-3-gallate resulted in the formation of internucleosomal DNA fragments, a 
characteristic of apoptosis. Treatment with epigallocatechin-3-gallate also resulted in 
apoptosis in HaCaT, L5178Y, and Du145 cells. The DNA cell cycle analysis showed that in 
A431 cells, epigallocatechin-3-gallate treatment resulted in arrest in the G0/G1 phase of cell 
cycle and a dose-dependent apoptosis. The G0/G1 arrest shown by epigallocatechin-3-
gallate, therefore suggested that this agent might slow down the growth of cancer cells by 
artificially imposing the cell cycle checkpoint. The loss of cell cycle checkpoint results in the 
selection of cells that have a growth advantage and a predisposition for acquiring more 
chromosomal aberrations.   
2.2. Coffee polyphenols 
Caffeic acid and chlorogenic acid are catechol-containing coffee polyphenols that, in a 
similar way to the tea polyphenols, have shown to be demethylating agents. Lee et al., 
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studied the modulating effects of these two compounds on the in vitro methylation of 
synthetic DNA substrates and also on the methylation status of the promoter region of 
RARβ in two human breast cancer cells lines [166]. The presence of caffeic acid or 
chlorogenic acid inhibited in a concentration-dependent manner the DNA methylation 
catalyzed by DNMT1, predominantly through a non-competitive mechanism. This 
inhibition, similar to other dietary polyphenols, was largely due to the increased formation 
of SAH. Treatment of MCF-7 and MAD-MB-231 human breast cancer cells with these two 
compounds partially inhibited the methylation of the promoter region of RARβ. 
Caffeic acid phenethyl ester (CAPE), which also is a chatechol, kills various types of cancer 
cells but is innocuous to normal cells. There are several studies reporting the in vitro and in 
vivo inhibitory ef1fects of CAPE in multiple cancer models, such as colon cancer [167], lung 
cancer [168], melanoma [169], glioma [170], pancreatic cancer [171], gastric cancer [172], 
cholangiocarcinoma [173], hepatocellular carcinoma [174], and breast cancer [175, 176]. 
2.3. Sulforaphane 
Sulforaphane, a dietary phytochemical obtained from broccoli, has been implicated in 
several physiological processes consistent with anticarcinogenic activity, including 
enhanced xenobiotic metabolism, cell cycle arrest, and apoptosis. Although the effect of 
sulforaphane as a demethylating agent has not been specifically studied, this compound 
was found to down regulate DNMT1 in CaCo-2 colon cancer cells [177]. 
2.4. Isothiocyanates 
Isothiocyanates comprise another class of dietary compounds known to affect the 
epigenome. Isothiocyanates are metabolites of glucosinolates present in a wide variety of 
cruciferous vegetables and demonstrated to have anticancer properties. Treatment of 
prostate cancer cells with phenethyl isothiocyanate, a metabolite of gluconasturtin from 
watercress, was shown to lead to demethylation and re-expression of GSTP1 [178]. On the 
other hand, treatment with different isothiocyanates prevented the esophageous 
tumorigenesis induced by the methylating agent N-nitrosomethylbenzylamine (NMBA) in 
male rats [179]. 
2.5. Curcumin 
Curcumin is a polyphenolic compound derived from the dietary spice turmeric and 
possesses diverse pharmacological effects including antioxidant, anti-inflammatory, anti-
proliferative, and anti-angiogenic activities. Curcumin has been used for centuries in Asia, 
both in traditional medicine and in cooking where curcumin gives natural yellow color to 
the food. It has been well known that curcumin possesses potent antiinflammatory activity 
because of its inhibitory effects on cyclooxygenases 1, 2 (COX-1, COX-2), lipoxygenase 
(LOX), TNF-α, interferon γ (IFN-γ), inducible nitric oxide synthase (iNOS), and NF-κB [180, 
181]. Importantly, experimental evidences suggest that curcumin could exert its inhibitory 
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effects on cancer development and progression. The mechanisms implicated in the 
inhibition of tumorigenesis by curcumin are unclear but could involve a combination of 
anti-oxidant, anti-proliferation, pro-apoptotic, and anti-angiogenic properties through the 
regulation of genes and molecules that are involved in multiple signaling pathways. 
Moreover, preclinical animal experiments and phase I clinical trials have demonstrated 
minimal toxicity of curcumin even at relatively high doses (12 g/day) [182]. However, 
curcumin exhibits poor bioavailability because of poor absorption and rapid metabolism 
[182]. To improve the bioavailability of curcumin, liposomal curcumin, nanoparticle 
curcumin, and structural analogs of curcumin have been synthesized and investigated to 
determine the absorption and anti-cancer activity [183, 184]. The results are promising, 
which further suggest that curcumin or its novel structural analogs could serve as potent 
agents for the prevention and/or treatment of human malignancies, and thus requires more 
phase II and III clinical trials. 
2.6. Rosmarinic acid 
Rosmarinic acid is a natural polyphenol antioxidant carboxylic acid found in many 
Lamiaceae herbs used commonly as culinary herbs such as lemon balm, rosemary, oregano, 
sage, thyme and peppermint. Rosmarinic acid has been recently shown to be a potent 
inhibitor of DNMT1 activity in nuclear extracts from MCF7 breast cancer cells and decrease 
the protein levels of DNMT1. However, this compound was unable to demethylate and 
reactivate known hypermethylated genes such as RASSF1A, GSTP1 and HIN-1 in this cell 
line (185). 
2.7. Resveratrol 
Resveratrol, a phytoalexin made naturally by several plants, has been produced by chemical 
synthesis because of its potential anti-cancer, anti-inflammatory, blood-sugar-lowering and 
other beneficial cardiovascular effects. There is limited evidence about the potential 
demethylating activity of this compound. Resveratrol has shown to be a weak DNMT 
activity inhibitor in nuclear extracts from MCF7 cells, and as rosmarinic acid, was unable to 
reverse the methylation of several tumor suppressor genes [185]. In MCF-7 cells, resveratrol 
improved the action of adenosine analogues to inhibit methylation and to increase 
expression of RARβ2, although without significant effect on its own [186]. 
3. Summary and conclusions 
There is traditional and widespread use of dietary polyphenols all around the world. While 
the anecdotal epidemiological evidence has historically supported the idea of different diet 
and good health, experimental evidence accumulated in the recent years from various 
preclinical and clinical studies clearly support the idea that dietary polyphenols have 
potentially beneficial effects on multitude of health conditions, including cancer. Although 
the health effects of dietary polyphenols in humans are generally considered promising, 
there are definite challenges and limitations of the current data in better understanding the 
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molecular mechanisms responsible for this effect, together with the possible interactions 
between different polyphenols and other dietary constituents. While in vitro models have 
enormously contributed to the understanding of polyphenols mediated regulation of the 
epigenetic network, there is still a paucity of in vivo data for the majority of these dietary 
compounds. Therefore, until sufficient preclinical and clinical data has been gathered on the 
epigenetic changes induced by some of the dietary polyphenols, one should be cautious 
while interpreting and extrapolating the significance of current in vitro evidence. Once such 
evidence is established, the next and more important step would be to determine the most 
effective doses of these ‘dietary nutraceuticals’ in order to obtain various beneficial effects in 
human subjects. 
Additional clinical work is required to examine the safety profile of various doses of dietary 
polyphenols, and more basic science studies are needed to improve our understanding of 
the molecular mechanisms underlying the chemopreventive effect of various dietary 
polyphenols. It is really exciting to witness that we have at least begun to explore the 
molecular mechanistic underpinnings of the “goodness” of certain diets and diet-related 
factors, which have been in existence for centuries. 
The mere fact that currently hundreds of dietary polyphenols are being characterized from 
an “epigenomic” perspective clearly reflects our enthusiasm and trust we pose in the 
concept of safe and natural agents for cancer chemoprevention. Of course, the current 
evidence is thin and it is a long and treacherous road ahead of us; nonetheless, given the 
promise and potential of these polyphenols it is realistic to fathom that some of these 
compounds can become integral for the cancer chemoprevention in future. 
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